• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌腋窝手术:过去、现在与未来。

Axillary surgery for breast cancer: past, present, and future.

作者信息

Noguchi Masakuni, Inokuchi Masafumi, Noguchi Miki, Morioka Emi, Ohno Yukako, Kurita Tomoko

机构信息

Breast Center, Kanazawa Medical University Hospital, Ishikawa, Japan.

Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Daigaku 1-1, Uchinada, Ishikawa, 920-0293, Japan.

出版信息

Breast Cancer. 2021 Jan;28(1):9-15. doi: 10.1007/s12282-020-01120-0. Epub 2020 Nov 9.

DOI:10.1007/s12282-020-01120-0
PMID:33165758
Abstract

In breast cancer surgery, there has been a major shift toward less invasive local treatment. Although axillary lymph node dissection (ALND) was an integral part of surgical treatment for breast cancer, sentinel lymph node (SLN) biopsy was developed as an accurate method for axillary staging. ALND can be avoided not only in patients with negative SLNs but also in those with one or two positive SLNs receiving breast and/or axillary radiation. On the other hand, ALND has remained the standard treatment for patients with clinically positive nodes. However, axillary reverse mapping (ARM) was developed to map and preserve arm lymphatic drainage during ALND and/or SLN biopsy. This procedure allowed reduction of the rate of arm lymphedema without increasing axillary recurrence, although patients receive postoperative chemotherapy and high-risk patients undergo axillary radiation. Standard ALND may not be necessary even for patients with clinically positive nodes who receive axillary radiation and systemic therapy. Thus, the extent of axillary surgery in breast cancer has been decreased with increased use of systemic and radiation therapy.

摘要

在乳腺癌手术中,已出现向侵入性较小的局部治疗的重大转变。尽管腋窝淋巴结清扫术(ALND)曾是乳腺癌手术治疗的一个组成部分,但前哨淋巴结(SLN)活检已发展成为一种准确的腋窝分期方法。不仅SLN阴性的患者,而且接受乳房和/或腋窝放疗的一两个SLN阳性的患者都可以避免进行ALND。另一方面,对于临床淋巴结阳性的患者,ALND仍然是标准治疗方法。然而,腋窝反向映射(ARM)技术的发展是为了在ALND和/或SLN活检过程中对臂部淋巴引流进行映射和保留。尽管患者接受术后化疗且高危患者接受腋窝放疗,但该手术能够在不增加腋窝复发率的情况下降低臂部淋巴水肿的发生率。即使对于接受腋窝放疗和全身治疗的临床淋巴结阳性的患者,标准的ALND可能也没有必要。因此,随着全身治疗和放疗的使用增加,乳腺癌腋窝手术的范围已经缩小。

相似文献

1
Axillary surgery for breast cancer: past, present, and future.乳腺癌腋窝手术:过去、现在与未来。
Breast Cancer. 2021 Jan;28(1):9-15. doi: 10.1007/s12282-020-01120-0. Epub 2020 Nov 9.
2
Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.接受保乳治疗的T1-2期乳腺癌伴前哨淋巴结大转移患者腋窝的处理
J Invest Surg. 2019 Jan;32(1):48-54. doi: 10.1080/08941939.2017.1375051. Epub 2017 Sep 25.
3
Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.最大限度减少腋窝淋巴结阳性乳腺癌患者腋窝清扫的范围和发病率:基于乳腺淋巴管水平的腋窝淋巴结清扫术的实施。
BMC Cancer. 2021 Mar 19;21(1):293. doi: 10.1186/s12885-021-08024-y.
4
Axillary reverse mapping (ARM): where to go.腋窝反向映射(ARM):何去何从。
Breast Cancer. 2019 Jan;26(1):1-10. doi: 10.1007/s12282-018-0886-0. Epub 2018 Jun 30.
5
Conservative axillary surgery is emerging in the surgical management of breast cancer.保守性腋窝手术正在乳腺癌的外科治疗中兴起。
Breast Cancer. 2023 Jan;30(1):14-22. doi: 10.1007/s12282-022-01409-2. Epub 2022 Nov 7.
6
Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.采用腋窝反向绘图技术筛查患淋巴水肿风险较高的乳腺癌患者。
World J Surg Oncol. 2020 Jun 1;18(1):118. doi: 10.1186/s12957-020-01886-9.
7
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.新辅助化疗后前哨淋巴结活检而不进行腋窝淋巴结清扫对选定患者准确且安全:GANEA 2 研究。
Breast Cancer Res Treat. 2019 Jan;173(2):343-352. doi: 10.1007/s10549-018-5004-7. Epub 2018 Oct 20.
8
Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.腋窝清扫术患者的腋窝逆向映射——文献复习。
Eur J Surg Oncol. 2020 Dec;46(12):2218-2220. doi: 10.1016/j.ejso.2020.07.026. Epub 2020 Aug 19.
9
A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.患者和评估者双盲随机对照试验评估早期乳腺癌患者腋窝反向绘图(ARM)。
Eur J Surg Oncol. 2020 Jan;46(1):59-64. doi: 10.1016/j.ejso.2019.08.003. Epub 2019 Aug 5.
10
Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.腋窝分期在妊娠期乳腺癌中的应用:前哨淋巴结活检的可行性和安全性。
Breast Cancer Res Treat. 2018 Apr;168(2):551-557. doi: 10.1007/s10549-017-4611-z. Epub 2017 Dec 12.

引用本文的文献

1
Development of a preoperative nomogram to identify low-risk early-stage breast cancer patients eligible for SLNB omission.开发一种术前列线图以识别适合省略前哨淋巴结活检的低风险早期乳腺癌患者。
World J Surg Oncol. 2025 Jul 7;23(1):268. doi: 10.1186/s12957-025-03921-z.
2
Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial.吲哚菁绿荧光引导下乳腺癌腋窝淋巴结清扫的腋窝反向映射:FARM试验
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17703-0.
3
Omission of Axillary Surgery After Neoadjuvant Therapy in Her2-Positive Breast Cancer: Who Are the Candidates?

本文引用的文献

1
Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.腋窝反向绘图(ARM)在临床腋窝淋巴结阴性乳腺癌患者中的评估——随机对照试验。
Int J Surg. 2020 Mar;75:174-178. doi: 10.1016/j.ijsu.2020.01.152. Epub 2020 Feb 12.
2
Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: a randomized controlled trial.乳腺癌手术后通过腋窝反向映射保留手臂淋巴结预防淋巴水肿:一项随机对照试验
Patient Saf Surg. 2019 Nov 14;13:35. doi: 10.1186/s13037-019-0217-1. eCollection 2019.
3
A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
人表皮生长因子受体2阳性乳腺癌新辅助治疗后腋窝手术的省略:哪些患者适合?
Cancers (Basel). 2025 Feb 7;17(4):562. doi: 10.3390/cancers17040562.
4
Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.在接受全乳切除术的临床 N0、前哨淋巴结阳性乳腺癌患者中跳过腋窝淋巴结清扫术的肿瘤安全性。
Ann Surg Oncol. 2024 May;31(5):3168-3176. doi: 10.1245/s10434-024-15049-7. Epub 2024 Feb 17.
5
Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.癌症进展中的淋巴结转移:分子机制、临床意义和治疗干预。
Signal Transduct Target Ther. 2023 Sep 27;8(1):367. doi: 10.1038/s41392-023-01576-4.
6
Deep Learning Radiomics Nomogram Based on Multiphase Computed Tomography for Predicting Axillary Lymph Node Metastasis in Breast Cancer.深度学习放射组学列线图基于多期 CT 预测乳腺癌腋窝淋巴结转移。
Mol Imaging Biol. 2024 Feb;26(1):90-100. doi: 10.1007/s11307-023-01839-0. Epub 2023 Aug 10.
7
The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy.治疗计划中的前哨淋巴结:淋巴引流引导放疗的叙述性综述
Cancers (Basel). 2023 May 12;15(10):2736. doi: 10.3390/cancers15102736.
8
Development and validation of a point-based scoring system for predicting axillary lymph node metastasis and disease outcome in breast cancer using clinicopathological and multiparametric MRI features.基于临床病理和多参数 MRI 特征的乳腺癌腋窝淋巴结转移和疾病结局预测的点评分系统的建立和验证。
Cancer Imaging. 2023 Jun 1;23(1):54. doi: 10.1186/s40644-023-00564-9.
9
Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study.T1-3N1 乳腺癌行靶向腋窝取样后 10 年的肿瘤学结果:一项回顾性研究。
Ann Surg Oncol. 2023 Aug;30(8):4669-4677. doi: 10.1245/s10434-023-13191-2. Epub 2023 Feb 24.
10
Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods.使用列线图和机器学习方法预测腋窝淋巴结对新辅助治疗的病理完全缓解
Front Oncol. 2022 Oct 24;12:1046039. doi: 10.3389/fonc.2022.1046039. eCollection 2022.
患者和评估者双盲随机对照试验评估早期乳腺癌患者腋窝反向绘图(ARM)。
Eur J Surg Oncol. 2020 Jan;46(1):59-64. doi: 10.1016/j.ejso.2019.08.003. Epub 2019 Aug 5.
4
Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial.在乳腺癌腋窝清扫术中识别和保护上肢淋巴系统以减少上肢淋巴水肿事件的随机临床试验。
Ann Surg Oncol. 2019 Oct;26(11):3446-3454. doi: 10.1245/s10434-019-07569-4. Epub 2019 Jun 25.
5
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.腋窝清扫与未清扫对乳腺癌伴前哨淋巴结微转移患者的影响(IBCSG 23-01):一项随机、对照、3 期临床试验的 10 年随访结果。
Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5.
6
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.腋窝淋巴结清扫术与非腋窝淋巴结清扫术对浸润性乳腺癌伴前哨淋巴结转移女性患者10年总生存率的影响:美国外科医师学会肿瘤学组Z0011(联盟)随机临床试验
JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.
7
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.OTOASOR试验的八年随访结果:早期乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗——手术或放疗:一项随机、单中心、III期、非劣效性试验。
Eur J Surg Oncol. 2017 Apr;43(4):672-679. doi: 10.1016/j.ejso.2016.12.011. Epub 2017 Jan 16.
8
Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.临床腋窝淋巴结阴性乳腺癌患者腋窝反向映射的可行性研究
Eur J Surg Oncol. 2016 May;42(5):650-6. doi: 10.1016/j.ejso.2016.02.244. Epub 2016 Mar 11.
9
Is axillary reverse mapping feasible in breast cancer patients?腋窝反向映射在乳腺癌患者中可行吗?
Eur J Surg Oncol. 2015 Apr;41(4):442-9. doi: 10.1016/j.ejso.2015.01.029. Epub 2015 Feb 10.
10
Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.腋窝反向绘图(ARM)在临床淋巴结阳性乳腺癌患者中的应用。
Eur J Surg Oncol. 2015 Jan;41(1):59-63. doi: 10.1016/j.ejso.2014.09.012. Epub 2014 Oct 29.